For those subscribed Simply Wall St has updated their report on AR9
archTIS AR9
Share Price 7 Day 1 Year
0.10 -2.4% -39.7% Full year 2023 earnings released: AU$0.03 loss per share (vs AU$0.038 loss in FY 2022) Full year 2023 results:
- AU$0.03 loss per share (improved from AU$0.038 loss in FY 2022).
- Revenue: AU$6.37m (up 37% from FY 2022).
- Net loss: AU$8.24m (loss narrowed 13% from FY 2022).
Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Software industry in Australia.
Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 41% per year, which means it is performing significantly worse than earnings.
archTIS (ASX:AR9) - Stock Price, News & Analysis - Simply Wall St
- Forums
- ASX - By Stock
- AR9
- Ann: Appendix 4E & 2023 Annual Report
Ann: Appendix 4E & 2023 Annual Report, page-17
Featured News
Add AR9 (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.003(4.35%) |
Mkt cap ! $20.63M |
Open | High | Low | Value | Volume |
6.9¢ | 7.2¢ | 6.9¢ | $13.03K | 183.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 320506 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 81155 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 320506 | 0.068 |
1 | 4477 | 0.067 |
3 | 175538 | 0.066 |
1 | 7698 | 0.065 |
1 | 20000 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 81155 | 2 |
0.075 | 10000 | 1 |
0.077 | 180000 | 1 |
0.078 | 10000 | 1 |
0.079 | 49500 | 1 |
Last trade - 15.57pm 18/11/2024 (20 minute delay) ? |
Featured News
AR9 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online